Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 337,739,904
  • Shares Outstanding, K 1,765,868
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.64
  • Price/Sales 6.29
  • Price/Cash Flow 12.26
  • Price/Book 50.19
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 21.12% ( -1.07%)
  • Historical Volatility 14.03%
  • IV Percentile 64%
  • IV Rank 38.79%
  • IV High 29.42% on 04/12/24
  • IV Low 15.86% on 03/01/24
  • Put/Call Vol Ratio 0.48
  • Today's Volume 18,321
  • Volume Avg (30-Day) 12,827
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 305,207
  • Open Int (30-Day) 351,545

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.95
  • Number of Estimates 10
  • High Estimate 3.00
  • Low Estimate 2.92
  • Prior Year 2.95
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
189.62 +1.21%
on 09/26/24
199.95 -4.03%
on 09/03/24
-5.54 (-2.81%)
since 08/26/24
3-Month
163.52 +17.36%
on 07/03/24
199.95 -4.03%
on 09/03/24
+20.75 (+12.12%)
since 06/26/24
52-Week
135.85 +41.26%
on 11/09/23
199.95 -4.03%
on 09/03/24
+37.99 (+24.68%)
since 09/26/23

Most Recent Stories

More News
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead

Even the mighty Novo Nordisk can't hold a candle to its peer in this area.

NVO : 124.30 (-2.09%)
ABBV : 191.90 (+0.33%)
AbbVie and SpinUp Foster Canadian Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award

/CNW/ - AbbVie (NYSE: ABBV), jointly with the University of Toronto's SpinUp, today announced the launch of the AbbVie Biotech Innovators Award, a national...

ABBV : 191.90 (+0.33%)
EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the regulatory filing seeking approval for its ovarian cancer drug Elahere (mirvetuximab...

AZN : 78.18 (+0.83%)
MRK : 113.09 (-1.43%)
ABBV : 191.90 (+0.33%)
PFE : 28.97 (+0.14%)
Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – The surge in...

ONCY : 0.8976 (-0.23%)
BGNE : 212.53 (+2.81%)
EXEL : 26.24 (+0.69%)
ABBV : 191.90 (+0.33%)
ONC.TO : 1.22 (-0.81%)
AMGN : 319.10 (+1.99%)
3 Dividend Powerhouses, Including One With 7% Yield

By investing in these dividend powerhouses, investors can achieve reliable income, mitigate risk through diversification, and potentially enjoy capital gains.

TU : 16.66 (+1.09%)
$SPX : 5,745.37 (+0.40%)
EPD : 28.88 (-1.26%)
ABBV : 191.90 (+0.33%)
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again

For over a decade, these two drugmakers consistently outperformed the benchmark index and could do it again.

ABBV : 191.90 (+0.33%)
AZN : 78.18 (+0.83%)
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?

The dividend growth powerhouse is turning the corner.

ABT : 112.73 (+0.11%)
ABBV : 191.90 (+0.33%)
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More

Financial factors aren't the only things that are worth paying attention to.

MRNA : 63.93 (+0.46%)
ABBV : 191.90 (+0.33%)
3 Stocks to Buy and Hold Forever

These stocks are built for the long run.

ABT : 112.73 (+0.11%)
ABBV : 191.90 (+0.33%)
LLY : 909.32 (-1.65%)
VRTX : 463.15 (+0.30%)
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Their dividends are solid. And their businesses are built for the long run.

ABBV : 191.90 (+0.33%)
BIP : 35.02 (+3.09%)
BIPC : 43.01 (+1.18%)
VZ : 44.62 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 196.56
2nd Resistance Point 194.72
1st Resistance Point 193.31
Last Price 191.90
1st Support Level 190.05
2nd Support Level 188.21
3rd Support Level 186.80

See More

52-Week High 199.95
Last Price 191.90
Fibonacci 61.8% 175.46
Fibonacci 50% 167.90
Fibonacci 38.2% 160.34
52-Week Low 135.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar